Texas Attorney General Ken Paxton (R) this week announced that his office will investigate two pharmaceutical companies accused of promoting hormone-blocking drugs for children with gender dysphoria despite the drugs not having received FDA approval for that use.

The Hill

Washington

District of Columbia

United States

Texas AG investigating pharmaceuticals over puberty blockers for children

Texas Attorney General Ken Paxton (R) this week announced that his office will investigate two pharmaceutical companies accused of promoting hormone-blocking drugs for children with gender dysphoria despite the drugs not having

Ad Fontes Media

All Sides

Media Bias/Fact Check

Nexstar Media Group

Texas Attorney General Ken Paxton announced Monday that he was opening an investigation into two pharmaceutical companies for promoting puberty-blocking drugs to minors for gender transitions.

Washington Examiner

Philip Anschutz

Texas Attorney General Ken Paxton to investigate drugmakers promoting puberty blockers to minors

Texas Attorney General Ken Paxton has announced an investigation into two pharmaceutical companies that allegedly promote the use of hormone blocking drugs for children.The drugs are not approved by the Food and Drug Administration for this purpose.Paxton’s office is looking into whether or not Endo Pharmaceuticals, Inc. and AbbVie Inc. violated the Texas Deceptive Trade Practices Act by promoting using the medications Supprelin LA and Lupron De…

The Gateway Pundit

Jim Hoft

Texas AG Investigating Pharmaceutical Companies That Promote Hormone Blockers for Kids

‘These drugs were approved for very different purposes and can have detrimental and even irreversible side effects,’ Paxton said.

National Review

Texas AG Probes Pharma Companies for Promoting Puberty Blockers for Trans Kids

Claims drugs promoted to treat gender dysphoria.

Spectrum Local News

Advance Publications

Liberty Media

Capital Group Companies

The Vanguard Group

Mitsubishi UFJ Financial Group

Nippon Life

Meiji Yasuda Life

Norinchukin Bank

Resona Holdings

Sumitomo Mitsui Trust Holdings

Masayoshi Son

JPMorgan Chase

Citigroup

Baillie Gifford

AG Paxton investigating pharmaceuticals over hormone-blocking drugs

AUSTIN (KXAN) — On Monday, Texas Attorney General Ken Paxton announced an investigation into two pharmaceutical companies he says promoted hormone blockers for children experiencing gender dysphoria.Paxton says Endo Pharmaceuticals Inc. and AbbVie Inc. are now being investigated under the Texas Deceptive Trade Practices Act. The AG's Office says the companies reportedly advertised and promoted Supprelin LA and Lupron Depot — medications used to …

KXAN

Austin

Travis County

Texas

Texas AG Paxton: Pharma companies giving kids hormone blockers without disclosure

Texas Attorney General Ken Paxton announced an investigation into two pharmaceutical companies that allegedly promoted hormone blocking drugs for children with gender dysphoria, even though the drugs have not been approved for this purpose. One of the companies told Fox News that it has not promoted the drugs for gender dysphoria.

Fox News

Murdoch family

Rupert Murdoch

New York

Texas AG Paxton investigates pharma companies over puberty blockers in trans kids: 'child abuse'

Texas AG investigating pharmaceuticals over puberty blockers for children

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics